Varespladib (LY315920) Appears to Be a Potent, Broad-Spectrum, Inhibitor of Snake Venom Phospholipase A2 and a Possible Pre-Referral Treatment for Envenomation

Snakebite remains a neglected medical problem of the developing world with up to 125,000 deaths each year despite more than a century of calls to improve snakebite prevention and care. An estimated 75% of fatalities from snakebite occur outside the hospital setting. Because phospholipase A2 (PLA2) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewin, Matthew, Samuel, Stephen, Merkel, Janie, Bickler, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037474/
https://www.ncbi.nlm.nih.gov/pubmed/27571102
http://dx.doi.org/10.3390/toxins8090248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5037474/
https://www.ncbi.nlm.nih.gov/pubmed/27571102
http://dx.doi.org/10.3390/toxins8090248

Ejemplares similares